| Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space. | 10/21 10:50 | investors.com |
| Wall Street Analysts Think Korro Bio, Inc. (KRRO) Could Surge 239.54%: Read This Before Placing a Bet | 10/16 10:55 | zacks.com |
| Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society | 09/30 08:00 | globenewswire.com |
| Korro to Participate in Upcoming September Investor and Scientific Conferences | 08/27 08:00 | globenewswire.com |
| Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates | 08/13 16:01 | globenewswire.com |
| Korro to Participate in Upcoming June Investor and Scientific Conferences | 05/30 16:01 | globenewswire.com |
| Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference | 05/20 14:30 | globenewswire.com |
| Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer | 05/14 16:01 | globenewswire.com |
| Korro Announces $70 Million Private Placement | 04/18 08:30 | globenewswire.com |
| Korro to Participate in Upcoming Investor Conferences | 04/01 16:01 | globenewswire.com |